Hamid Rabb

Can choice of dialyser membrane have a beneficial effect on HIV load in the HIV-infected dialysis patient?

Use of a bovine model to study the role of adhesion molecule CD11/CD18 in hemodialysis-induced neutropenia.

The T cell as a bridge between innate and adaptive immune systems: implications for the kidney.

15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure.

Utility and limitations of serum creatinine as a measure of renal function in experimental renal ischemia-reperfusion injury.

Pathophysiological contributions of fucosyltransferases in renal ischemia reperfusion injury.

Protective effect of T cell depletion in murine renal ischemia-reperfusion injury.

Protective effect of HMG-CoA reductase inhibitor on experimental renal ischemia-reperfusion injury.

Silent acute rejection during prolonged delayed graft function reduces kidney allograft survival.

The role of adhesion molecules and T cells in ischemic renal injury.

Expression of SSAT, a novel biomarker of tubular cell damage, increases in kidney ischemia-reperfusion injury.

Continuous dialysis as systemic therapy in the critically ill patient?

Acute renal failure leads to dysregulation of lung salt and water channels.

Acute renal failure after whole body ischemia is characterized by inflammation and T cell-mediated injury.

Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury.

Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog.

Novel urinary markers for early diagnosis of ARF.

B cell deficiency confers protection from renal ischemia reperfusion injury.

Renal expression and activity of the germinal center kinase SK2.

Stem-cell therapy for renal diseases.

Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury.

Identification of stathmin as a novel marker of cell proliferation in the recovery phase of acute ischemic renal failure.

Muscling in on systemic inflammatory response syndrome.

National conference to assess antibody-mediated rejection in solid organ transplantation.

Surrogate markers for long-term renal allograft survival.

Overexpression of SSAT in kidney cells recapitulates various phenotypic aspects of kidney ischemia-reperfusion injury.

Inflammatory cells in ischemic acute renal failure.

Mechanisms underlying combined acute renal failure and acute lung injury in the intensive care unit.

Renal transplantation at the Johns Hopkins Comprehensive Transplant Center.

Isometric tubular epithelial vacuolization in renal allograft biopsy specimens of patients receiving low-dose intravenous immunoglobulin for a positive crossmatch.

Immune responses in kidney preservation and reperfusion injury.

Limiting deleterious cross-talk between failing organs.

Persistent renal and extrarenal immune changes after severe ischemic injury.

Effects of combined T- and B-cell deficiency on murine ischemia reperfusion injury.

Paracrine and differentiation mechanisms underlying stem cell therapy for the damaged kidney.

Clinical results from transplanting incompatible live kidney donor/recipient pairs using kidney paired donation.

EPO therapy during acute kidney disease: to use or not to use, that is the question.

Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia.

Keratinocyte-derived chemokine is an early biomarker of ischemic acute kidney injury.

Stathmin-deficient mice develop fibrosis and show delayed recovery from ischemic-reperfusion injury.

Immune modulation of acute kidney injury.

A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity.

Ischemic acute tubular necrosis models and drug discovery: a focus on cellular inflammation.

Long-term outcome of renal transplantation from older donors.

Decreased capacity of immune cells to cause tissue injury mediates kidney ischemic preconditioning.

Upregulation of EphA2 during in vivo and in vitro renal ischemia-reperfusion injury: role of Src kinases.

Transfer of lymphocytes from mice with renal ischemia can induce albuminuria in naive mice: a possible mechanism linking early injury and progressive renal disease?

Domino paired kidney donation: a strategy to make best use of live non-directed donation.

Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury.

Does statin pretreatment reduce the risk of contrast-induced nephropathy?

Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury.

Impact of ischemia times on kidney transplant outcomes.

Ischemic acute kidney injury induces a distant organ functional and genomic response distinguishable from bilateral nephrectomy.

Case records of the Massachusetts General Hospital. Case 31-2007. A 41-year-old man with abdominal pain and elevated serum creatinine.

Ischemia-reperfusion and immediate T cell responses.

Arteriosclerosis in kidneys from healthy live donors: comparison of wedge and needle core perioperative biopsies.

The local and systemic inflammatory transcriptome after acute kidney injury.

Effects of acid aspiration-induced acute lung injury on kidney function.

Acute kidney injury leads to inflammation and functional changes in the brain.

Pravastatin improves renal ischemia-reperfusion injury by inhibiting the mevalonate pathway.

Normal mouse kidneys contain activated and CD3+CD4- CD8- double-negative T lymphocytes with a distinct TCR repertoire.

Uremic lung: new insights into a forgotten condition.

Distant-organ changes after acute kidney injury.

Interactive effects of mechanical ventilation and kidney health on lung function in an in vivo mouse model.

The innate immune response in ischemic acute kidney injury.

Lymphocytes and ischemia-reperfusion injury.

Renal ischemia-reperfusion leads to long term infiltration of activated and effector-memory T lymphocytes.

DNA testing for live kidney donors at risk for autosomal dominant polycystic kidney disease.

Kidney-derived stromal cells modulate dendritic and T cell responses.

Effect of T cells on vascular permeability in early ischemic acute kidney injury in mice.

Diverse sources of stem cells to treat acute kidney injury.

Kidney ischemia-reperfusion injury induces caspase-dependent pulmonary apoptosis.

Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice.

Kidney-lung crosstalk in the critically ill patient.

The role for T cell repertoire/antigen-specific interactions in experimental kidney ischemia reperfusion injury.

The interaction between ischemia-reperfusion and immune responses in the kidney.

Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury.

Early exposure to germs modifies kidney damage and inflammation after experimental ischemia-reperfusion injury.

The effect of murine anti-thymocyte globulin on experimental kidney warm ischemia-reperfusion injury in mice.

Organ crosstalk: the role of the kidney.

Kidney transplantation in the elderly.

Immunologic research in kidney ischemia/reperfusion injury at Johns Hopkins University.

Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition.

B cells limit repair after ischemic acute kidney injury.

Mycophenolate mofetil modifies kidney tubular injury and Foxp3+ regulatory T cell trafficking during recovery from experimental ischemia-reperfusion.

Renal transplant in Wegener's granulomatosis compared to microscopic polyangiitis.

Kidney-derived mesenchymal stromal cells modulate dendritic cell function to suppress alloimmune responses and delay allograft rejection.

Molecular imaging of the kidneys.

Effects of anti-adhesive therapy on kidney biomarkers of ischemia reperfusion injury in human deceased donor kidney allografts.

Urinary biomarkers in acute kidney transplant dysfunction.

Pulmonary endothelial cell activation during experimental acute kidney injury.

Blocking Fas ligand on leukocytes attenuates kidney ischemia-reperfusion injury.

Kidney transplantation in HIV-infected patients.

The distant organ effects of acute kidney injury.

Delayed kidney allograft function - what does it tell us about acute kidney injury?

Interleukin-6 mediates pulmonary vascular permeability in a two-hit model of ventilator-associated lung injury.

Acute renal venous obstruction is more detrimental to the kidney than arterial occlusion: implication for murine models of acute kidney injury.

Transcriptional analysis of infiltrating T cells in kidney ischemia-reperfusion injury reveals a pathophysiological role for CCR5.

Glucose reintroduction triggers the activation of Nrf2 during experimental ischemia reperfusion.

African American and non-African American patients' and families' decision making about renal replacement therapies.

Lung T lymphocyte trafficking and activation during ischemic acute kidney injury.

The providing resources to enhance African American patients' readiness to make decisions about kidney disease (PREPARED) study: protocol of a randomized controlled trial.

The promise of immune cell therapy for acute kidney injury.

Development of a decision aid to inform patients' and families' renal replacement therapy selection decisions.

Selecting renal replacement therapies: what do African American and non-African American patients and their families think others should know? A mixed methods study.

A prospective controlled study of kidney donors: baseline and 6-month follow-up.

Adiponectin: an enlarging role in acute kidney injury.

Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).

Cardiorenal syndrome type 5: clinical presentation, pathophysiology and management strategies from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).

Comparison of life participation activities among adults treated by hemodialysis, peritoneal dialysis, and kidney transplantation: a systematic review.

Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy.

The Nrf2 triterpenoid activator, CDDO-imidazolide, protects kidneys from ischemia-reperfusion injury in mice.

Meta-analysis of molecular response of kidney to ischemia reperfusion injury for the identification of new candidate genes.

HuR and other turnover- and translation-regulatory RNA-binding proteins: implications for the kidney.